Elawyers Elawyers
Ohio| Change

BAYHI v. NOVARTIS PHARMACEUTICALS CORPORATION, 2:14-cv-00885-TLN-DAD. (2014)

Court: District Court, E.D. California Number: infdco20140806741 Visitors: 18
Filed: Aug. 05, 2014
Latest Update: Aug. 05, 2014
Summary: STIPULATION AND ORDER STAYING FURTHER PROCEEDINGS PENDING RULING ON SUMMARY JUDGMENT MOTION TROY L. NUNLEY, District Judge. Pursuant to Local Rule 143(b), all parties hereby stipulate and seek an order as follows: RECITALS WHEREAS, defendant Novartis Pharmaceuticals Corporation ("Novartis") filed a summary judgment motion on July 30, 2014. See Novartis' Notice of Motion and Motion for Summary Judgment Based on Statute of Limitations (ECF No. 23). WHEREAS, Novartis' summary judgment mot
More

STIPULATION AND ORDER STAYING FURTHER PROCEEDINGS PENDING RULING ON SUMMARY JUDGMENT MOTION

TROY L. NUNLEY, District Judge.

Pursuant to Local Rule 143(b), all parties hereby stipulate and seek an order as follows:

RECITALS

WHEREAS, defendant Novartis Pharmaceuticals Corporation ("Novartis") filed a summary judgment motion on July 30, 2014. See Novartis' Notice of Motion and Motion for Summary Judgment Based on Statute of Limitations (ECF No. 23).

WHEREAS, Novartis' summary judgment motion, if granted, will dispose of all claims alleged in this lawsuit.

WHEREAS, Novartis' summary judgment motion has been noticed for hearing on September 11, 2014.

WHEREAS, the Court previously directed the parties to confer about and submit a joint status report. See Order Requiring Joint Status Report (ECF No. 13).

WHEREAS, the parties agree that, in the interest of conserving resources, it is appropriate to stay all further proceedings in this lawsuit (including submitting a joint status report) — except for any hearing on Novartis' pending summary judgment motion and any deadlines for further briefing on that motion — until the Court has ruled on that motion.

STIPULATION

THEREFORE, the parties hereby stipulate and request that the Court stay all further proceedings in this lawsuit (including submitting a joint status report) — except for any hearing on Novartis' pending summary judgment motion and any deadlines for further briefing on that motion — until the Court has ruled on that motion.

IT IS SO ORDERED.

Source:  Leagle

Can't find what you're looking for?

Post a free question on our public forum.
Ask a Question
Search for lawyers by practice areas.
Find a Lawyer